For the Inventor, By the Inventor

Enter inventor name

Millington, NJ, United States of America

Bob Dale Brown

USPTO Granted Patents = 92 (Patent Applications = 48)

CIPO Patents = 9 (Patent Applications = 30)

EPO Patents = 17 (Patent Applications = 46)

Average Co-Inventor Count = 1.9

ph-index = 14

Forward Citations = 762(Granted Patents)

Forward Citations (Not Self Cited) = 633(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Diego, CA (US) (2003 - 2010)
Encinitas, CA (US) (1999 - 2012)
Cambridge, MA (US) (2021)
Millington, NJ (US) (2013 - 2022)
Littleton, MA (US) (2016 - 2024)
Lexington, MA (US) (2022 - 2024)

Company Filing History:

Dicerna Pharmaceuticals, Inc.

Promega Biosciences, Inc.

Genta Incorporated

4. 4 out of 819

Gen-probe, Inc.

Oasis Biosciences Incorporated

Years Active: 1999-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

LPA Expression Inhibition

APOC3 Modulation

PNPLA3 Modulation

Double-Stranded RNA Inhibition

Gene Expression Inhibition

Alpha-1 Antitrypsin Inhibition

Glycolate Oxidase Inhibition

Transthyretin Inhibition

Antithrombin 3 Inhibition

Lactate Dehydrogenase Inhibition

KRAS Inhibition

Amine Cationic Lipids

92 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435336 - Compositions and methods for inhibiting LPA expression (2025-10-07),

2. 12252691 - Compositions and methods for inhibiting LPA expression (2025-03-18),

3. 12234456 - Compositions and methods for modulating APOC3 expression (2025-02-25),

4. 12084662 - Compositions and methods for modulating PNPLA3 expression (2024-09-10),

5. 12077756 - Extended dicer substrate agents and methods for the specific inhibition of gene expression (2024-09-03),

6. 11912996 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2024-02-27),

7. 11873493 - Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA (2024-01-16),

8. 11873488 - Double-stranded nucleic acid inhibitor molecules modified with Tm-increasing nucleotides (2024-01-16),

9. 11851658 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2023-12-26),

10. 11773390 - Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA (2023-10-03),

11. 11697812 - Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA (2023-07-11),

12. 11667918 - Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA (2023-06-06),

13. 11661604 - Methods and compositions for inhibiting expression of LDHA (2023-05-30),

14. 11634713 - Extended dicer substrate agents and methods for the specific inhibition of gene expression (2023-04-25),

15. 11597929 - Extended dicer substrate agents and methods for the specific inhibition of gene expression (2023-03-07),

Title: The Inventor Bob Dale Brown: Revolutionizing Technology in Millington, NJ

Introduction: Bob Dale Brown is a visionary inventor based in Millington, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Bob Dale Brown holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Bob Dale Brown has worked tirelessly to bring cutting-edge ideas to life, leading to the development of numerous revolutionary products and solutions.

Collaborations: Throughout his career, Bob Dale Brown has collaborated with leading tech companies, research institutions, and universities to further advance the boundaries of innovation and create impactful technologies.

Conclusion: Bob Dale Brown's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the field of invention, with a lasting impact on the world of innovation in Millington, NJ.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…